Omslagafbeelding van de show Ozempic vs Wegovy — What's the Difference?

Ozempic vs Wegovy — What's the Difference?

Podcast door Inception Point AI

Engels

Gezondheid & Persoonlijke Ontwikkeling

Daarna € 9,99 / maand. Elk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts

Over Ozempic vs Wegovy — What's the Difference?

Discover why semaglutide exists as two FDA-approved drugs with different purposes and doses. Julia Cartwright unravels the regulatory decisions and dosing science that distinguish Ozempic for diabetes from Wegovy for weight management. Learn what doctors consider when choosing between them and why insurance might make the decision for you. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle afleveringen

4 afleveringen

aflevering Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking artwork

Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking

Julia Cartwright examines what doctors really consider when prescribing Ozempic versus Wegovy—the same semaglutide molecule with different FDA approvals, dosing, and insurance coverage. From BMI thresholds and prior authorizations to off-label use and cost barriers, this episode unpacks the complex medical and bureaucratic factors shaping your prescription in ways you never realized. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 25 min
aflevering Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels artwork

Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels

Join host Julia Cartwright as she unravels how one molecule—semaglutide—became two FDA-approved drugs with distinct missions. We explore the clinical trials, regulatory decisions, and dosing strategies that split Ozempic (for diabetes) from Wegovy (for weight management), revealing why this distinction matters for patients, coverage, and modern medicine's evolving approach to treating chronic disease. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 26 min
Meld je aan om te luisteren
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Tijdelijke aanbieding

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

2 maanden voor € 1
Daarna € 9,99 / maand

Begin hier

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 7 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Veelgestelde vragen

Meer vragen & antwoorden
Begin hier

2 maanden voor € 1. Daarna € 9,99 / maand. Elk moment opzegbaar.